iBio (IBIO) Interest & Investment Income (2010 - 2026)
iBio's (IBIO) quarterly Interest & Investment Income came in at $657000.0 in Q1 2026, up 812.5% year-on-year from $72000.0 in Q1 2025, and up 33.27% on a QoQ basis from $493000.0 in Q4 2025.
iBio (IBIO) Interest & Investment Income (2010 - 2026) Analysis & Trends
iBio (IBIO) has 17 years of Interest & Investment Income data on file, last reported at $657000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 812.5% year-over-year to $657000.0 in Q1 2026; TTM through Mar 2026 was $1.5 million, a 157.49% increase from a year earlier, with the FY2025 full-year figure at $437000.0, up 20.39% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $657000.0, up from $493000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for IBIO reached as high as $657000.0 in Q1 2026 and fell as low as $23000.0 in Q1 2023.
- Historically, Interest & Investment Income has averaged $149176.5 across 5 years, with a median of $72000.0 in 2025.
- Across the five-year window, Interest & Investment Income plunged 73.68% in 2022 and jumped 812.5% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $41000.0 in 2022, then gained by 2.44% to $42000.0 in 2023, then jumped by 166.67% to $112000.0 in 2024, then soared by 340.18% to $493000.0 in 2025, then surged by 33.27% to $657000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $657000.0 in Q1 2026, $493000.0 in Q4 2025, and $267000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 657,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 657,000.00 |
| Dec 31, 2025 | 493,000.00 |
| Sep 30, 2025 | 267,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | 174,000.00 |
| Jun 30, 2024 | 223,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 41,000.00 |
| Sep 30, 2022 | 99,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | 36,000.00 |
| Jun 30, 2021 | -43,000.00 |